Trial
NCT05703607
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
BioNTech SE
Condition
Shingles
Intervention
Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
Why stopped
Strategic decision made by the company
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-04